Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
John Pauling, PhD, BSc, FRCP, MBBCH
North Bristol NHS Trust
Bristol, United Kingdom
Disclosure(s): Astra Zenaca: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Janssen: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Permeatus Inc: Consultant (Ongoing); Sojournix Pharma: Consultant (Ongoing)
Lorinda Chung, MD, MS
Stanford University
Woodside, CA, United States
Disclosure information not submitted.
Elizabeth Volkmann, MD, MS
Associate Professor, Division of Rheumatology
University of California, Los Angeles
Los Angeles, CA, United States
Disclosure information not submitted.
Hilde Bjørkekjær, MD
Department of Rheumatology, Sørlandet sykehus HF, Kristiansand
Kristiansand, Norway
Disclosure information not submitted.
Francesco Del Galdo, MD, PhD
University of Leeds
Leeds, United Kingdom
Disclosure(s): No relevant disclosure to display
Clinical Science Poster Highlights: Abstracts #1047, #1049, #2170